Your browser doesn't support javascript.
loading
Use of follow-on fingolimod for multiple sclerosis: Analysis of effectiveness and patient reported outcomes in a real-world clinical setting.
Altunan, Bengü; Ünal, Aysun; Efendi, Hüsnü; Köseoglu, Mesrure; Terzi, Murat; Kotan, Dilcan; Tamam, Yusuf; Boz, Cavit; Güler, Sibel; Turan, Ömer Faruk; Altunrende, Burcu; Balci, Fatma Belgin; Turgut, Nilda; Akçali, Aylin; Yildirim, Kadriye Agan; Günal, Dilek Ince; Sunter, Gulin; Bingöl, Ayhan.
Affiliation
  • Altunan B; Department of Neurology, Faculty of Medicine, Tekirdag Namik Kemal University, Kampus street,.Süleymanpasa, Tekirdag 59100, Turkey.
  • Ünal A; Department of Neurology, Faculty of Medicine, Tekirdag Namik Kemal University, Kampus street,.Süleymanpasa, Tekirdag 59100, Turkey. Electronic address: aysuneu@yahoo.com.
  • Efendi H; Department of Neurology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey.
  • Köseoglu M; Bakirköy Research and Training Hospital, Istanbul, Turkey.
  • Terzi M; Department of Neurology, Ondokuz Mayis University, Samsun, Turkey.
  • Kotan D; Department of Neurology, Faculty of Medicine, Sakarya University, Sakarya, Turkey.
  • Tamam Y; Department of Neurology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey.
  • Boz C; Department of Neurology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
  • Güler S; Department of Neurology, Faculty of Medicine, Trakya University, Edirne, Turkey.
  • Turan ÖF; Department of Neurology, Faculty of Medicine, Bursa Uludag University, Bursa, Turkey.
  • Altunrende B; Bilim University, Florence Nightingale Hospital, Istanbul, Turkey.
  • Balci FB; Haseki Research and Training Hospital, Istanbul, Turkey.
  • Turgut N; Department of Neurology, Faculty of Medicine, Tekirdag Namik Kemal University, Kampus street,.Süleymanpasa, Tekirdag 59100, Turkey.
  • Akçali A; Department of Neurology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey.
  • Yildirim KA; Department of Neurology, Faculty of Medicine, Marmara University, Istanbul, Turkey.
  • Günal DI; Department of Neurology, Faculty of Medicine, Marmara University, Istanbul, Turkey.
  • Sunter G; Department of Neurology, Faculty of Medicine, Marmara University, Istanbul, Turkey.
  • Bingöl A; Davranis Degisim Akademisi, Istanbul, Turkey.
Mult Scler Relat Disord ; 77: 104880, 2023 Sep.
Article de En | MEDLINE | ID: mdl-37459716
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Sclérose en plaques récurrente-rémittente / Sclérose en plaques Type d'étude: Clinical_trials / Guideline / Observational_studies Aspects: Patient_preference Limites: Humans Langue: En Journal: Mult Scler Relat Disord Année: 2023 Type de document: Article Pays d'affiliation: Turquie
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Sclérose en plaques récurrente-rémittente / Sclérose en plaques Type d'étude: Clinical_trials / Guideline / Observational_studies Aspects: Patient_preference Limites: Humans Langue: En Journal: Mult Scler Relat Disord Année: 2023 Type de document: Article Pays d'affiliation: Turquie